Cargando…

Advances in the proteomic discovery of novel therapeutic targets in cancer

Proteomic approaches are continuing to make headways in cancer research by helping to elucidate complex signaling networks that underlie tumorigenesis and disease progression. This review describes recent advances made in the proteomic discovery of drug targets for therapeutic development. A variety...

Descripción completa

Detalles Bibliográficos
Autores principales:	Guo, Shanchun, Zou, Jin, Wang, Guangdi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2013
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3810204/ https://www.ncbi.nlm.nih.gov/pubmed/24187485 http://dx.doi.org/10.2147/DDDT.S52216

Ejemplares similares

Glutathione peroxidases as oncotargets
por: Jiao, Yang, et al.
Publicado: (2017)

Discovery of Novel Allopurinol Derivatives with Anticancer Activity and Attenuated Xanthine Oxidase Inhibition
por: Li, Yong, et al.
Publicado: (2016)

Recent Advances in Proteomics and Cancer Biomarker Discovery
por: Xiao, Gary Guishan, et al.
Publicado: (2008)

Lung Cancer Proteomics: Recent Advances in Biomarker Discovery
por: Indovina, Paola, et al.
Publicado: (2011)

GREB1 Functions as a Growth Promoter and Is Modulated by IL6/STAT3 in Breast Cancer
por: Liu, Mingli, et al.
Publicado: (2012)

Harnessing Omics Approaches on Advanced Preclinical Models to Discovery Novel Therapeutic Targets for the Treatment of Metastatic Colorectal Cancer
por: Porru, Manuela, et al.
Publicado: (2020)

Synergistic effects of combined treatment with histone deacetylase inhibitor suberoylanilide hydroxamic acid and TRAIL on human breast cancer cells
por: Zhou, Weiqiang, et al.
Publicado: (2016)

TRPM7 Induces Mechanistic Target of Rap1b Through the Downregulation of miR-28-5p in Glioma Proliferation and Invasion
por: Wan, Jingwei, et al.
Publicado: (2019)

Clinical proteomics: a driving force for cancer therapeutic target discovery and precision medicine
por: Wang, Hao, et al.
Publicado: (2019)

Design, Synthesis, and Evaluation of Niclosamide Analogs as Therapeutic Agents for Enzalutamide-Resistant Prostate Cancer
por: Kang, Borui, et al.
Publicado: (2023)

The Role of Proteomics and Phosphoproteomics in the Discovery of Therapeutic Targets and Biomarkers in Acquired EGFR-TKI-Resistant Non-Small Cell Lung Cancer
por: Moonmuang, Sutpirat, et al.
Publicado: (2023)

SAT-341 Pharmacology and Metabolism of GLL398 an Oral Selective Estrogen Receptor Degrader for Endocrine Therapy of Breast Cancer
por: Guo, Shanchun, et al.
Publicado: (2019)

Proteomics for the discovery of nuclear bile acid receptor FXR targets()
por: Gardmo, Cissi, et al.
Publicado: (2011)

The Proteomics Big Challenge for Biomarkers and New Drug-Targets Discovery
por: Savino, Rocco, et al.
Publicado: (2012)

Proteomic landscape of Alzheimer’s Disease: novel insights into pathogenesis and biomarker discovery
por: Bai, Bing, et al.
Publicado: (2021)

Recent Advancement in Drug Design and Discovery of Pyrazole Biomolecules as Cancer and Inflammation Therapeutics
por: Alam, Md. Jahangir, et al.
Publicado: (2022)

Discovery, Function, and Therapeutic Targeting of Siglec-8
por: Youngblood, Bradford A., et al.
Publicado: (2020)

Strategies for translating proteomics discoveries into drug discovery for dementia
por: Halder, Aditi, et al.
Publicado: (2023)

Proteomics and genomics: perspectives on drug and target discovery
por: Ahn, Natalie G, et al.
Publicado: (2008)

Advances in Drug Discovery Targeting Lysosomal Membrane Proteins
por: Wang, Hongna, et al.
Publicado: (2023)

Lymphatic metastasis in non‐small cell lung cancer: recent discoveries and novel therapeutic targets
por: Diao, Xiayao, et al.
Publicado: (2022)

Proteomics in Cancer Biomarkers Discovery: Challenges and Applications
por: Sallam, Reem M.
Publicado: (2015)

Metabolism and Pharmacokinetic Study of the Boron-Containing Prodrug of Belinostat (ZL277), a Pan HDAC Inhibitor with Enhanced Bioavailability
por: Zhang, Changde, et al.
Publicado: (2019)

TYK2 in Cancer Metastases: Genomic and Proteomic Discovery
por: Borcherding, Dana C., et al.
Publicado: (2021)

Metagenomics and novel gene discovery: Promise and potential for novel therapeutics
por: Culligan, Eamonn P, et al.
Publicado: (2014)

Recent Advances in the Discovery of Novel Antiprotozoal Agents
por: Lee, Seong-Min, et al.
Publicado: (2019)

Advances in the discovery of exosome inhibitors in cancer
por: Zhang, Huarui, et al.
Publicado: (2020)

CRISPR Screen Contributes to Novel Target Discovery in Prostate Cancer
por: Tsujino, Takuya, et al.
Publicado: (2021)

Targeting bromodomain-containing proteins: research advances of drug discovery
por: Pan, Zhaoping, et al.
Publicado: (2023)

Clinical proteomics for liver disease: a promising approach for discovery of novel biomarkers
por: Uto, Hirofumi, et al.
Publicado: (2010)

Targeting JWA for Cancer Therapy: Functions, Mechanisms and Drug Discovery
por: Ding, Kun, et al.
Publicado: (2022)

Secretome Proteomic Approaches for Biomarker Discovery: An Update on Colorectal Cancer
por: Cevenini, Armando, et al.
Publicado: (2020)

Proteomic Analysis of Exosomes for Discovery of Protein Biomarkers for Prostate and Bladder Cancer
por: Wang, Yi-Ting, et al.
Publicado: (2020)

Revisiting biomarker discovery by plasma proteomics
por: Geyer, Philipp E, et al.
Publicado: (2017)

Editorial: Novel therapeutic target and drug discovery for neurological diseases
por: Zhao, Kaiyue, et al.
Publicado: (2022)

Targeting autophagic pathways for cancer drug discovery
por: Liu, Bo, et al.
Publicado: (2013)

Elesclomol, a copper-transporting therapeutic agent targeting mitochondria: from discovery to its novel applications
por: Tarin, Mojtaba, et al.
Publicado: (2023)

Advances in Antisense Oligonucleotide Development for Target Identification, Validation, and as Novel Therapeutics
por: Mansoor, Moizza, et al.
Publicado: (2008)

Metabolism, pharmacokinetics, and bioavailability of ZB716, a Steroidal Selective Estrogen Receptor Downregulator (SERD)
por: Zhang, Changde, et al.
Publicado: (2017)

Small molecule metabolites: discovery of biomarkers and therapeutic targets
por: Qiu, Shi, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_dicn10agukmpqsqv5u88hf7a8r